Abstract
3α-Methoxyserrat-14-en-21β-ol ( 1) and 3β-methoxyserrat-14-en-21β-ol ( 2) and their conjugates with curcumin, kojic acid, quercetin, and baicalein ( 3– 18), as well as new analogs ( 19– 24) derived from 1 and 2, were tested for their inhibitory effects on Epstein-Barr virus early antigen (EBV-EA) activation induced by 12- O-tetradecanoylphorbol-13-acetate (TPA). The inhibitory effects of 16 (IC 50 = 330 mol ratio/32 pmol/TPA), 9 (IC 50 = 335), 10 (IC 50 = 338), and 15 (IC 50 = 350) were stronger than those of the other compounds and the positive control, oleanolic acid (IC 50 = 449). Compounds 15 and 16, which are conjugates of one molecule each of 1 or 2 and quercetin, inhibited mouse skin tumor promotion in an in vivo two-stage carcinogenesis model. The in vivo two-stage mouse skin carcinogenesis test employed 7,12-dimethylbenz[a]anthracene (DMBA) as an initiator and TPA as a promoter.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
